AACR Annual Meeting 2019: Past, Present, and Future of CDK4/6-targeted Therapeutics
Therapeutics that target two proteins called cyclin-dependent kinase 4 (CDK4) and CDK6 have revolutionized treatment for breast cancer, Richard...
Therapeutics that target two proteins called cyclin-dependent kinase 4 (CDK4) and CDK6 have revolutionized treatment for breast cancer, Richard...
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new treatments for cancer continued last week...